View Post

The first person to be saved by whole genome sequencing

Huntsville, Ala. — The story of a groundbreaking genomic medicine case led by HudsonAlpha researchers is now available. “One in a Billion: The Story of Nic Volker and the Dawn of Genomic Medicine” (Simon & Schuster, April 2016), follows the diagnostic odyssey of Nic Volker, the first person to be saved by whole genome sequencing. Volker, a young child suffering …

View Post

“Liquid biopsy” blood test accurately detects key genetic mutations in most common form of lung cancer, study finds

BOSTON – A simple blood test can rapidly and accurately detect mutations in two key genes in non-small cell lung tumors, researchers at Dana-Farber Cancer Institute and other institutions report in a new study – demonstrating the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting those mutations. The test, known as a liquid …

View Post

R-Biopharm AG and Merck KGaA, Darmstadt, Germany enter into collaboration on developing and launching Companion Diagnostics

Darmstadt, Germany, March 22, 2016 – R-Biopharm AG announced today it has entered into an agreement with Merck KGaA, Darmstadt, Germany to collaborate on developing companion diagnostics. The agreement constitutes the first collaboration between the two companies, covering research, development and launching of novel companion diagnostics. The project provides framework for further collaborations across a potentially wide range of therapeutic …

View Post

£6m for Scottish Genomes Partnership

Minister for Sport, Health Improvement and Mental Health, Jamie Hepburn has announced a £6 million investment in the Scottish Genomes Partnership (SGP) The SGP is a collaboration of Scottish Universities and the NHS capitalising on £15 million investment in whole genome sequencing technology by the Universities of Edinburgh and Glasgow. The Scottish Government is contributing £4 million and the Medical Research …

View Post

Findacure says it could save NHS £m with drug repurposing

2,200 babies will be born in the UK on 29th February, of which 30 will die of a rare disease before they are five years old*. UK charity Findacure believes that existing drugs may hold the key to new treatments and repurposing could save the NHS millions of pounds. Dr Richard Thompson, Scientific Officer of Findacure, says: “Only around 400 of …

View Post

Further £250m in funding for genomics in the UK

Further £250m in funding for genomics in the UK – and cancer patients being recruited for 100K Genome Project Across England patients with cancer are now being recruited to the main phase of the 100,000 Genomes Project, giving the fight against cancer a significant boost. Minister for Life Sciences George Freeman MP announced the news at the Festival of Genomics …

View Post

Kraft Family Foundation Pledges $20m to Create the Kraft Endowment for Advancing Precision Medicine

Kraft Family Foundation, Inc., has pledged $20 million to Harvard Business School (HBS) to create the Kraft Endowment for Advancing Precision Medicine. The pledge, which is part of Harvard University’s $6.5 billion capital campaign, was announced at the Partners Precision Medicine Conference at Harvard Medical School, with Robert Kraft in attendance. The Kraft Endowment will be used to support research …

View Post

Northern Ireland Joins the 100,000 Genomes Project

Health Minister in the Northern Ireland Executive, Simon Hamilton, today announced £3.3m investment to create a Northern Ireland Genomic Medicine Centre that will provide rare disease patients with a much earlier and more accurate diagnosis. It is estimated that 1 in 17 people are born with or develop a rare disease during their lifetime. At least 80% of rare diseases …

View Post

Initial six centres of excellence in UK PM network named Teams in Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford

The Precision Medicine Catapult, the UK’s innovation centre for precision medicine, announces today that Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford will be the initial locations for its regional centres of excellence network. Each centre will act as a hub for regional precision medicine activities within the UK-wide network, co-ordinated from the Cambridge headquarters. The Catapults are a UK Government …